Akèy › Lukemi lenfositè kwonik › Pennsylvania › York
Etid klinik pou Lukemi lenfositè kwonik nan York, PA
3 etid pou Lukemi lenfositè kwonik ap chèche patisipan nan sit nan ak bò kote York (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Ap rekriteFaz 3
- Cancer Care Associates of York, York
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Ap rekriteFaz 3
- Cancer Care Associates Of York ( Site 0005), York
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Ap rekriteFaz 2
- Cancer Care Associates Of York, York
Etid Lukemi lenfositè kwonik nan lòt vil
- Boston, MA31 etid
- Columbus, OH28 etid
- Durham, NC27 etid
- Washington, DC22 etid
- Seattle, WA20 etid
- Rochester, MN19 etid
- New York City, NY18 etid
- Houston, TX17 etid
- Baldwin Park, CA16 etid
- Milwaukee, WI15 etid
- Cincinnati, OH14 etid
- Chicago, IL14 etid
Lòt etid nan York
- Kansè Poumon ki pa ti selil15 etid
- Kansè poumon8 etid
- Kansè (tout kalite)8 etid
- Kansè nan tete8 etid
- Karsinòm selil skuamèz tèt ak kou7 etid
- Kansè ovè6 etid
- Kansè pwostat5 etid
- Maladi atè koronè5 etid
- Kansè kolorektal4 etid
- Kansè Endomèt4 etid
- Kansè tete negatif triple4 etid
- Kansè Ezofajyen4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.